Search

everythinglearnresearchcommunity

for

Search:↓

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

In the Jazan region of Saudi Arabia, hair loss is common, especially among women, older people, and those with higher education and BMI. Stress, poor nutrition, and hormonal changes are key causes, but many don't seek medical help.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Elderly patients have more severe hidradenitis suppurativa and may need different treatments.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Younger women are seen as more attractive and healthier, with Chinese women rated highest and South African women rated oldest and least healthy.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Vitamin D supplements improve bone pain, tiredness, hair loss, and mood, especially in women and older adults.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

High LH levels cause hair loss by damaging and aging hair follicles.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

Most postmenopausal women experience significant skin changes and various skin conditions.

Nanotechnology therapies can help improve quality of life for those with hair loss.

Aging-related hormone changes affect voice quality, especially during puberty, menstruation, pregnancy, and menopause.

Female pattern hair loss causes significant hair thinning and affects self-confidence.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Women generally want more hair volume, which becomes a concern around menopause due to hair loss.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.